High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks or even months for it to be most effective,” lead researcher Dr. Richard ...

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.

But a recently approved daily migraine pill called Qulipta (atogepant) appears to be effective from day one in many patients, clinical trial data shows. Patients taking Qulipta had a 37% to 61% ...

Other drugs in AbbVie's lineup, including Botox, migraine therapies Qulipta and Ubrelvy, cancer drug Venclexta, and antipsychotic medication Vrayalar, are also delivering strong sales growth.

(Alzheimer's & Dementia) In phase III studies of episodic or chronic migraine prevention, oral atogepant (Qulipta) showed efficacy and improved functional measures within the first 4 weeks of ...